IHC 3+ HER2 expression in gastric adenocarcinoma

Low-power view of immunohistochemistry (IHC) for human epidermal growth factor receptor 2 (HER2) expression in a gastric adenocarcinoma showing strong, complete, basolateral membranous reactivity in ≥10% of tumor cells (score 3+).